Rho GTPases in neurodegeneration diseases

Experimental Cell Research

Volumn 319, Issue 15, 2013, Pages 2384-2394

  DeGeer, Jonathan ^a   Lamarche Vane, Nathalie ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Nerve injury; Neurite outgrowth; Neurodegeneration; Rho GTPases; RhoGAPs; RhoGEFs

Indexed keywords

GUANOSINE TRIPHOSPHATASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; DISEASES; GLAUCOMA; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUNTINGTON CHOREA; NERVE DEGENERATION; NERVE INJURY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 84883245283     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.06.016     Document Type: Review

References (116)

1. Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 2005, 21:247-269.
2. Vega FM, Ridley AJ. SnapShot: Rho family GTPases. Cell 2007, 129:1430.
3. Zheng Y. Dbl family guanine nucleotide exchange factors. Trends Biochem. Sci. 2001, 26:724-732.
4. Tcherkezian J, Lamarche-Vane N. Current knowledge of the large RhoGAP family of proteins. Biol. Cell 2007, 99:67-86.
5. Olofsson B. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell. Signalling 1999, 11:545-554.
6. Côté JF, Motoyama AB, Bush JA, Vuori K. A novel and evolutionarily conserved PtdIns(3,4,5)P3-binding domain is necessary for DOCK180 signalling. Nat. Cell Biol. 2005, 7:797-807.
7. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992, 70:389-399.
8. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992, 70:401-410.
9. Nobes CD, Hall A.Rho Rac and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia and filopodia. Cell 1995, 81:53-62.
10. Edwards DC, Sanders LC, Bokoch GM, Gill GN. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat. Cell Biol. 1999, 1:253-259.
11. Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K, et al. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 1998, 393:809-812.
12. Sanders LC, Matsumura F, Bokoch GM, de Lanerolle P. Inhibition of myosin light chain kinase by p21-activated kinase. Science 1999, 283:2083-2085.
13. Eblen ST, Slack JK, Weber MJ, Catling AD. Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes. Mol. Cell. Biol. 2002, 22:6023-6033.
14. Zhang S, Han J, Sells MA, Chernoff J, Knaus UG, Ulevitch RJ, et al. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J. Biol. Chem. 1995, 270:23934-23936.
15. Bagrodia S, Derijard B, Davis RJ, Cerione RA. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 1995, 270:27995-27998.
16. Lamarche N, Tapon N., Stowers L., Burbelo P.D., Aspenstrom P., Bridges T., Chant J., Hall A. Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade. Cell 1996, 87:519-529.
17. Rohatgi R, Ma L, Miki H, Lopez M, Kirchhausen T, Takenawa T, et al. The interaction between N-WASP and the Arp2/3 complex links Cdc42- dependent signals to actin assembly. Cell 1999, 97:221-231.
18. Machesky LM, Mullins RD, Higgs HN, Kaiser DA, Blanchoin L, May RC, et al. Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2/3 complex. Proc. Nat. Acad. Sci. U.S.A. 1999, 96:3739-3744.
19. Pollitt AY, Insall RH. WASP and SCAR/WAVE proteins: the drivers of actin assembly. J. Cell Sci. 2009, 122:2575-2578.
20. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, et al. Regulation of myosin phosphatase by rho and rho-associated kinase (rho-kinase). Science 1996, 273:245-248.
21. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 1999, 285:895-898.
22. Ohashi K, Nagata K, Maekawa M, Ishizaki T, Narumiya S, Mizuno K. Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J. Biol. Chem. 2000, 275:3577-3582.
23. Palazzo AF, Cook TA, Alberts AS, Gundersen GG. mDia mediates Rho-regulated formation and orientation of stable microtubules. Nat. Cell Biol. 2001, 3:723-729.
24. Govek EE, Newey SE, Van Aelst L. The role of the Rho GTPases in neuronal development. Genes Dev. 2005, 19:1-49.
25. Lowery LA, Van Vactor D. The trip of the tip: understanding the growth cone machinery. Nat Rev Mol. Cell. Biol. 2009, 10:332-343.
26. Li X, Saint-Cyr-Proulx E, Aktories K, Lamarche-Vane N. Rac1 and Cdc42 but not RhoA or Rho kinase activities are required for neurite outgrowth induced by the Netrin-1 receptor DCC (deleted in colorectal cancer) in N1E-115 neuroblastoma cells. J. Biol. Chem. 2002, 277:15207-15214.
27. Antoine-Bertrand J, Villemure JF, Lamarche-Vane N. Implication of Rho GTPases in neurodegenerative diseases. Curr. Drug Targets 2011, 12:1202-1215.
28. Atwal JK, Pinkston-Gosse J, Syken J, Stawicki S, Wu Y, Shatz C, et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Sci. Rep. 2008, 322:967-970.
29. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002, 420:74-78.
30. Park JB, Yiu G, Kaneko S, Wang J, Chang J, He XL, et al. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 2005, 45:345-351.
31. Singh KK, Park KJ, Hong EJ, Kramer BM, Greenberg ME, Kaplan DR, et al. Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration. Nat. Neurosci. 2008, 11:649-658.
32. Park KJ, Grosso CA, Aubert I, Kaplan DR, Miller FD. p75NTR-dependent, myelin-mediated axonal degeneration regulates neural connectivity in the adult brain. Nat. Neurosci. 2010, 13:559-566.
33. Yamashita T, Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat. Neurosci. 2003, 6:461-467.
34. Harrington AW, Li QM, Tep C, Park JB, He Z, Yoon SO. The role of Kalirin9 in p75/nogo receptor-mediated RhoA activation in cerebellar granule neurons. J. Biol. Chem. 2008, 283:24690-24697.
35. Niederöst B, Oertle T, Fritsche J, McKinney RA, Bandtlow CE. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J. Neurosci. 2002, 22:10368-10376.
36. Fournier AE, Takizawa BT, Strittmatter SM. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 2003, 23:1416-1423.
37. Borisoff JF, Chan CC, Hiebert GW, Oschipok L, Robertson GS, Zamboni R, et al. Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates. Mol. Cell. Neurosci. 2003, 22:405-416.
38. Schulz A, Baader SL, Niwa-Kawakita M, Jung MJ, Bauer R, Garcia C, et al. Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy. Nat. Neurosci. 2013, 16:426-433.
39. Fry EJ, Ho C, David S. A role for Nogo receptor in macrophage clearance from injured peripheral nerve. Neuron 2007, 53:649-662.
40. Jung J, Cai W, Lee HK, Pellegatta M, Shin YK, Jang SY, et al. Actin polymerization is essential for myelin sheath fragmentation during Wallerian degeneration. J. Neurosci. 2011, 31:2009-2015.
41. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 2004, 27:723-749.
42. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
43. Yamanaka K, Miller TM, McAlonis-Downes M, Chun SJ, Cleveland DW. Progressive spinal axonal degeneration and slowness in ALS2-deficient mice. Ann. Neurol. 2006, 60:95-104.
44. Yamanaka K, Vande Velde C, Eymard-Pierre E, Bertini E, Boespflug-Tanguy O, Cleveland DW. Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease. Proc. Nat. Acad. Sci. 2003, 100:16041-16046.
45. Otomo A, Hadano S, Okada T, Mizumura H, Kunita R, Nishijima H, et al. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum. Mol. Genet. 2003, 12:1671-1687.
46. Tudor EL, Perkinton MS, Schmidt A, Ackerley S, Brownlees J, Jacobsen NJ, et al. ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowth. J. Biol. Chem. 2005, 280:34735-34740.
47. Kanekura K, Hashimoto Y, Kita Y, Sasabe J, Aiso S, Nishimoto I, et al. A Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. J. Biol. Chem. 2005, 280:4532-4543.
48. Figueroa-Romero C, Hur J, Bender DE, Delaney CE, Cataldo MD, Smith AL, et al. Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS One 2012, 7:e52672.
49. Blanke S, Jäckle H. Novel guanine nucleotide exchange factor GEFmeso of Drosophila melanogaster interacts with Ral and Rho GTPase Cdc42. FASEB J. 2006, 20:683-691.
50. Oliver AW, He X, Borthwick K, Donne AJ, Hampson L, Hampson IN. The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42. Br. J. Cancer 2011, 104:324-331.
51. Wong K, Ren XR, Huang YZ, Xie Y, Liu G, Saito H, et al. Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell 2001, 107:209-221.
52. Lansbury PT, Lashuel HA. A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 2006, 443:774-779.
53. Huesa G, Baltrons MA, Gómez-Ramos P, Morán A, García A, Hidalgo J, et al. Altered distribution of RhoA in Alzheimer's disease and AbetaPP overexpressing mice. J. Alzheimers Dis. 2010, 19:37-56.
54. Zhou Y, Su Y, Li B, Liu F, Ryder JW, Wu X, et al. Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science 2003, 302:1215-1217.
55. Petratos S LQ, George AJ, Hou X, Kerr ML, Unabia SE, Hatzinisiriou I, Maksel D, Aguilar MI, Small DH. The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 2008, 131:90-108.
56. Adamson P, Marshall CJ, Hall A, Tilbrook PA. Post-translational modifications of p21rho proteins. J. Biol. Chem. 1992, 267:20033-20038.
57. Mohamed A, Saavedra L, Di Pardo A, Sipione S, Posse de Chaves E. β-amyloid inhibits protein prenylation and induces cholesterol sequestration by impairing SREBP-2 cleavage. J. Neurosci. 2012, 32:6490-6500.
58. Cook M, Mani P, Wentzell J, Kretzschmar D. Increased RhoA prenylation in the loechrig (loe) mutant leads to progressive neurodegeneration. PLoS One 2012, 7:e44440.
59. Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 1998, 21:516-520.
60. Huang TY, Michael S, Xu T, Sarkeshik A, Moresco JJ, Yates JR, et al. A novel Rac1 GAP splice variant relays poly-Ub accumulation signals to mediate Rac1 inactivation. Mol. Biol. Cell 2012, 24:194-209.
61. Zhao L, Ma QL, Calon F, Harris-White ME, Yang F, Lim GP, et al. Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat. Neurosci. 2006, 9:234-242.
62. Mendoza-Naranjo A, Gonzalez-Billault C, Maccioni RB. Abeta 1-42 stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTPases. J. Cell Sci. 2007, 120:279-288.
63. Youn H, Ji I, Ji H, Markesbery W, Ji T. Under-expression of Kalirin-7 increases iNOS activity in cultured cells and correlates to elevated iNOS activity in Alzheimer's disease hippocampus. J. Alzheimers Dis. 2007, 12:271-281.
64. Aliev G, Palacios HH, Lipsitt AE, Fischbach K, Lamb BT, Obrenovich ME, et al. Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. Neurotox. Res. 2009, 16:293-305.
65. Rosario M, Schuster S, Juttner R, Parthasarathy S, Tarabykin V, Birchmeier W. Neocortical dendritic complexity is controlled during development by NOMA-GAP-dependent inhibition of Cdc42 and activation of cofilin. Genes Dev. 2012, 26:1743-1757.
66. Rosario M, Franke R, Bednarski C, Birchmeier W. The neurite outgrowth multiadaptor RhoGAP, NOMA-GAP, regulates neurite extension through SHP2 and Cdc42. J. Cell Biol. 2007, 178:503-516.
67. Capsoni S, Ugolini G, Comparini A, Ruberti F, Berardi N, Cattaneo A. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. PNAS 2000, 97:6826-6831.
68. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 1999, 97:395-406.
69. Brabeck C, Beschorner R, Conrad S, Mittelbronn M, Bekure K, Meyermann R, et al. Lesional expression of RhoA and RhoB following traumatic brain injury in humans. J. Neurotrauma 2004, 21:697-706.
70. Trapp T, Korhonen L, Besselmann M, Martinez R, Mercer EA, Lindholm D. Transgenic mice overexpressing XIAP in neurons show better outcome after transient cerebral ischemia. Mol. Cell. Neurosci. 2003, 23:302-313.
71. Kamasani U, Prendergast GC. Genetic response to DNA damage: proapoptotic targets of RhoB include modules for p53 response and susceptibility to Alzheimer's disease. Cancer Biol. Ther. 2005, 4:282-288.
72. Barberan S, McNair K, Iqbal K, Smith NC, Prendergast GC, Stone TW, et al. Altered apoptotic responses in neurons lacking RhoB GTPase. Eur. J. Neurosci. 2011, 34:1737-1746.
73. Kashiwa A, Yoshida H, Lee S, Paladino T, Liu Y, Chen Q, et al. Isolation and characterization of novel presenilin binding protein. J. Neurochem. 2000, 75:109-116.
74. Namekata K, Harada C, Taya C, Guo X, Kimura H, Parada LF, et al. Dock3 induces axonal outgrowth by stimulating membrane recruitment of the WAVE complex. PNAS 2010, 107:7586-7591.
75. Namekata K, Harada C, Guo X, Kimura A, Kittaka D, Watanabe H, et al. Dock3 stimulates axonal outgrowth via GSK-3β-mediated microtubule assembly. J. Neurosci. 2012, 32:264-274.
76. Chen Q, Kimura H, Schubert D. A novel mechanism for the regulation of amyloid precursor protein metabolism. J. Cell Biol. 2002, 158:79-89.
77. Chen Q, Yoshida H, Schubert D, Maher P, Mallory M, Masliah E. Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation. Am. J. Pathol. 2001, 159:1597-1602.
78. Chen Q, Peto CA, Shelton GD, Mizisin A, Sawchenko PE, Schubert D. Loss of modifier of cell adhesion reveals a pathway leading to axonal degeneration. J. Neurosci. 2009, 29:118-130.
79. Bai N, Hayashi H, Aida T, Namekata K, Harada T, Mishina M, et al. Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity. Mol. Brain 2013, 6:22.
80. Ross CA. Huntington's disease: new paths to pathogenesis. Cell 2004, 118:4-7.
81. Colomer V, Engelender S, Sharp AH, Duan K, Cooper JK, Lanahan A, et al. Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain. Hum. Mol. Genet. 1997, 6:1519-1525.
82. Mandela P, Ma XM. Kalirin, a key player in synapse formation, is implicated in human diseases. Neural Plast. 2012, 2012:728161.
83. Hayashi-Takagi A, Takaki M, Graziane N, Seshadri S, Murdoch H, Dunlop AJ, et al. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 2010, 13:327-332.
84. Peng YJ, He WQ, Tang J, Tao T, Chen C, Gao YQ, et al. Trio is a key guanine nucleotide exchange factor coordinating regulation of the migration and morphogenesis of granule cells in the developing cerebellum. J. Biol. Chem. 2010, 285:24834-24844.
85. Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, Buckley NJ. A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol. Dis. 2008, 29:438-445.
86. Vo N, Klein ME, Varlamova O, Keller DM, Yamamoto T, Goodman RH, et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc. Nat. Acad. Sci. 2005, 102:16426-16431.
87. Holbert S, Dedeoglu A, Humbert S, Saudou F, Ferrante RJ, Néri C. Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease. Proc. Nat. Acad. Sci. 2003, 100:2712-2717.
88. Tian L, Nelson DL, Stewart DM. Cdc42-interacting protein 4 mediates binding of the Wiskott-Aldrich syndrome protein to microtubules. J. Biol. Chem. 2000, 275:7854-7861.
89. Pollitt SK, Pallos J, Shao J, Desai UA, Ma AA, Thompson LM, et al. A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor. Neuron 2003, 40:685-694.
90. Shao J, Welch WJ, Diprospero NA, Diamond MI. Phosphorylation of profilin by ROCK1 regulates polyglutamine aggregation. Mol. Cell. Biol. 2008, 28:5196-5208.
91. Varma H, Yamamoto A, Sarantos MR, Hughes RE, Stockwell BR. Mutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathway. J. Biol. Chem. 2010, 285:37445-37457.
92. Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003, 302:819-822.
93. Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 2009, 8:1150-1157.
94. Tanaka M, Kim YM, Lee G, Junn E, Iwatsubo T, Mouradian MM. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J. Biol. Chem. 2004, 279:4625-4631.
95. Tsai YC, Riess O, Soehn AS, Nguyen HP. The Guanine nucleotide exchange factor Kalirin-7 is a novel synphilin-1 interacting protein and modifies synphilin-1 aggregate transport and formation. PLoS One 2012, 7:e51999.
96. Chan D, Citro A, Cordy JM, Shen GC, Wolozin B. Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2). J. Biol. Chem. 2011, 286:16140-16149.
97. Barcia C, Ros CM, Annese V, Carrillo-de Sauvage MA, Ros-Bernal F, Gómez A, et al. ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo. Sci. Rep. 2012, 2:809.
98. Fujikawa K, Iwata T, Inoue K, Akahori M, Kadotani HF,M., Watanabe M, et al. VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans. PLoS One 2010, 5:e9050.
99. Turner M, Billadeau DD. VAV proteins as signal integrators for multi-subunit immune-recognition receptors. Nat. Rev. Immunol. 2002, 2:476-486.
100. Fu CT, Sretavan D. Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 2012, 53:76-84.
101. Skre H. Genetic and clinical aspects of Charcot-Marie-tooth's disease. Clin. Genet. 1974, 6:98-118.
102. Dyck PJ, Chance P, Lebo R, Camey AJ. Hereditary motor and sensory neuropathies. Peripheral Neuropathy 1993, 1094-1136. W.B. Saunders, Philadelphia. third ed. P.J. Dyck, P.K. Thomas, J.W. Griffin, P.A. Low, J.F. Poduslo (Eds.).
103. Verhoeven K, De Jonghe P, Van de Putte T, Nelis E, Zwijsen A, Verpoorten N, et al. Slowed conduction and thin myelination of peripheral nerves associated with mutant rho Guanine-nucleotide exchange factor 10. Am. J. Hum. Genet. 2003, 73:926-932.
104. Chaya T, Shibata S, Tokuhara Y, Yamaguchi W, Matsumoto H, Kawahara I, et al. Identification of a negative regulatory region for the exchange activity and characterization of T332I mutant of Rho guanine nucleotide exchange factor 10 (ARHGEF10). J. Biol. Chem. 2011, 286:29511-29520.
105. Stendel C, Roos A, Deconinck T, Pereira J, Castagner F, Niemann A, et al. Peripheral nerve demyelination caused by a mutant Rho GTPase guanine nucleotide exchange factor, frabin/FGD4. Am. J. Hum. Genet. 2007, 81:158-164.
106. Horn M, Baumann R, Pereira JA, Sidiropoulos PN, Somandin C, Welzl H, et al. Myelin is dependent on the Charcot-Marie-tooth type 4H disease culprit protein FRABIN/FGD4 in Schwann cells. Brain 2012, 135:3567-3583.
107. Maystadt I, Rezsöhazy R, Barkats M, Duque S, Vannuffel P, Remacle S, et al. The nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset. Am. J. Hum. Genet. 2007, 81:67-76.
108. Perona R, Montaner S, Saniger L, Sánchez-Pérez I, Bravo R, Lacal JC. Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev. 1997, 11:463-475.
109. Barger SW, Moerman AM, Mao X. Molecular mechanisms of cytokine-induced neuroprotection: NFkappaB and neuroplasticity. Curr. Pharm. Des. 2005, 11:985-998.
110. Talens-Visconti R, Peris B, Guerri C, Guasch RM. RhoE stimulates neurite-like outgrowth in PC12 cells through inhibition of the RhoA/ROCK-I signalling. J. Neurochem. 2010, 112:1074-1087.
111. Mocholí E, Ballester-Lurbe B, Arqué G, Poch E, Peris B, Guerri C, et al. RhoE deficiency produces postnatal lethality, profound motor deficits and neurodevelopmental delay in mice. PLoS One 2011, 6:e19236.
112. Goh LL, Manser E. The RhoA GEF Syx is a target of Rnd3 and regulated via a Raf1-like ubiquitin-related domain. PLoS One 2010, 5:e12409.
113. Wennerberg K, Forget MA, Ellerbroek SM, Arthur WT, Burridge K, Settleman J, et al. Rnd proteins function as RhoA antagonists by activating p190 RhoGAP. Curr. Biol. 2003, 13:1106-1115.
114. Riento K, Guasch RM, Garg R, Jin B, Ridley AJ. RhoE binds to ROCK I and inhibits downstream signaling. Mol. Cell. Biol. 2003, 23:4219-4229.
115. Peris B, Gonzalez-Granero S, Ballester-Lurbe B, García-Verdugo JM, Pérez-Roger I, Guerri C, et al. Neuronal polarization is impaired in mice lacking RhoE expression. J. Neurochem. 2012, 121:903-914.
116. Wang S, Xu B, Liou LC, Ren Q, Huang S, Luo Y, et al. α-Synuclein disrupts stress signaling by inhibiting polo-like kinase Cdc5/Plk2. Proc. Nat. Acad. Sci. 2012, 109:16119-16124.